John M. Kalas practices in the Firm's Complex Litigation, Environmental, Pharmaceutical Products, and Toxic Torts & Products Liability groups. His practice is focused on deconstructing the opposition’s core corporate liability and scientific theories. To that end, he has taken and defended dozens of successful depositions of expert and fact witnesses. He has participated in several multi-day Daubert hearings and has significant trial experience as a member of multiple trial teams in jurisdictions nationwide.

Currently, Mr. Kalas is serving as trial counsel in litigation involving exposures to agricultural chemicals and persistent organic pollutants that have allegedly led to the development of lymphatic cancer. In his most recent trial in this litigation, he conducted multiple successful cross-examinations of plaintiff's key fact and expert witnesses. He also conducted a direct examination of a regulatory witness in the case and argued multiple successful motions in pre-trial proceedings and throughout the course of trial. The case reached a favorable outcome for the client.

Mr. Kalas is part of the defense team representing an agricultural company in litigation involving claims of cancer from exposure to pesticides, centralized in a Multi-District Litigation before the United States District Court for the Northern District of California. Cases are also situated in various state courts nationwide. As part of that litigation, he has led a team focused on developing experts to evaluate exposure and dose issues and on deconstructing the theories of plaintiffs' exposure, dose, and toxicology experts.

Mr. Kalas also currently represents a pharmaceutical corporation in litigation involving alleged impurities in an FDA-approved prescription medication. As part of his work in this litigation, he has focused on developing expert witnesses to examine the scientific issues pertinent to the case.

In the past, Mr. Kalas litigated personal injury and property damage claims following alleged exposure to perchlorate and other volatile organic compounds from groundwater contamination, and defended wrongful death claims associated with alleged exposure to airborne toxins in international litigation spanning three continents. He has defended birth defect claims allegedly associated with occupational and residential chemical exposure, and has represented employers seeking to enforce choice-of-law and arbitration agreements contained within employees’ employment contracts. He also played a substantial role in the defense of Novartis Pharmaceuticals Corporation in bisphosphonate litigation centralized in Tennessee and New Jersey. He contributed significantly to motions practice in that litigation, researching and drafting scores of successful dispositive and Daubert motions.

Mr. Kalas is a member of the Atlantic Legal Foundation Science Advisory Committee and a member of the Defense Research Institute.


  • Old and New Targets: IARC Releases its 2020-2024 Priority List for Evaluation
  • "Super-Size My Litigation? Perfluorochemicals And Food Packaging"
  • Nestle Takes Shelter in Its Supply Chain Safe Harbor
  • The Road to Denial: An Analysis of the Trends and Bases for Denial of Multidistrict Litigation Requests
  • Issuer Banks and Data Breach Lawsuits: A New Wave of Litigation?
  • High Court's Cert Denial Foments Greater Confusion Over Removal of Mass Actions Under Federal Law